Sapho Bio provides rapid RNA based sterility testing for pharmaceutical products.
Sapho Bio has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in April 2026.
Sapho Bio's investors include Mochi Health.
Sapho Bio is headquartered in San Carlos, United States.
Sapho Bio provides rapid RNA based sterility testing for pharmaceutical products.
Sapho Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sapho Bio — Funding & Investors." VCBacked, April 29, 2026, https://www.vcbacked.co/company/sapho-bio. Accessed October 30, 2026.
VCBacked. (2026). Sapho Bio — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/sapho-bio
{{cite web |title=Sapho Bio — Funding & Investors |url=https://www.vcbacked.co/company/sapho-bio |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated